Nephrogenic Systemic Fibrosis With Gadollinum

Summary

Recently there is increasing reports of NEPHROGENIIC SYSTEMIC FIBROSIS(NSF) in patients with severe renal failure mainly in patients under dialysis in whom gadollinum is being used. The investigators will evaluate the prevalence and severity of NSF in patients with different degree of renal failure whom underwent imaging with Gadolinum.

Timeline

Start

2008-07

Primary completion

2011-05

Completion

2012-08

Drugs

Indications